Baird Financial Group, Inc.

Source: SEC Form 13F · as of Mar 2026

Baird Financial Group, Inc. holds 67 biotech & pharma companies tracked by BioSniper, totaling $2.90B in value as of Mar 2026 (SEC Form 13F).

Companies held

67

Total value held

$2.90B

CompanySharesValue
JNJJOHNSON & JOHNSON4,524,578$1.11B
ABBVAbbVie Inc.1,950,203$424.1M
LLYELI LILLY & Co283,474$260.7M
ABTABBOTT LABORATORIES1,733,915$178.0M
MRKMerck & Co., Inc.1,163,093$139.9M
AMGNAMGEN INC334,329$117.6M
ONCBeOne Medicines Ltd.349,651$103.8M
PFEPFIZER INC2,310,997$64.9M
IDXXIDEXX LABORATORIES INC /DE82,535$46.4M
REGNREGENERON PHARMACEUTICALS, INC.57,589$44.5M
PMPhilip Morris International Inc265,912$44.0M
GILDGILEAD SCIENCES, INC.282,089$39.3M
MCKMcKesson Corporation38,117$33.0M
UNHUnitedHealth Group Incorporated Common Stock (DE)105,767$28.6M
BMYBRISTOL MYERS SQUIBB CO468,115$28.4M
AZNASTRAZENECA PLC133,378$26.3M
CAHCardinal Health Inc.98,276$20.8M
RGENREPLIGEN CORP171,630$20.2M
ZTSZoetis Inc.154,225$18.2M
INCYIncyte Corp.186,860$17.6M
CORCencora Inc.51,961$16.3M
WSTWest Pharmaceutical Services Inc.57,287$14.4M
NVONovo Nordisk A/S320,799$11.8M
NVSNovartis AG67,212$10.3M
GEHCGE HealthCare Technologies Inc.141,744$10.1M
IQVIQVIA Holdings Inc.53,899$9.2M
SNYSanofi141,110$6.8M
NBIXNEUROCRINE BIOSCIENCES INC38,589$5.1M
VRTXVERTEX PHARMACEUTICALS INC / MA8,771$3.9M
TECHBIO-TECHNE Corp66,869$3.5M
DGXQuest Diagnostics Incorporated16,328$3.2M
ALHCAlignment Healthcare Inc.171,014$3.0M
BBIOBridgeBio Pharma, Inc.40,531$3.0M
TARSTarsus Pharmaceuticals, Inc.41,977$2.9M
INSMINSMED Inc17,688$2.9M
LGNDLigand Pharmaceuticals Incorporated12,981$2.6M
TWSTTwist Bioscience Corp53,867$2.6M
KNSAKiniksa Pharmaceuticals International, plc40,249$1.9M
ZBHZimmer Biomet Holdings Inc.21,372$1.9M
GMOptec International, Inc.24,658$1.8M
VTRSViatris Inc135,046$1.8M
LNTHLantheus Holdings, Inc.23,343$1.8M
DVADaVita Inc.11,343$1.7M
ELVElevance Health Inc.5,156$1.5M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)23,839$1.3M
SUNSUNSET ISLAND GROUP15,068$979K
RPRXRoyalty Pharma plc20,000$959K
PCVXVaxcyte, Inc.13,788$801K
BIIBBIOGEN INC.4,213$772K
BAXBaxter International Inc.44,246$743K
ALTAltimmune, Inc.237,522$732K
IOVAIOVANCE BIOTHERAPEUTICS, INC.198,540$697K
HALOHALOZYME THERAPEUTICS, INC.10,694$691K
PAHCPHIBRO ANIMAL HEALTH CORP10,431$577K
OSCROscar Health Inc.31,584$362K
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.1,875$323K
MEDPMedpace Holdings Inc.640$307K
SRPTSarepta Therapeutics, Inc.11,904$259K
MRNAModerna, Inc.4,781$243K
MIRMMirum Pharmaceuticals, Inc.2,305$213K
PBIPROVENTION BIO, INC.17,783$197K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)10,081$187K
MYGNMYRIAD GENETICS INC38,338$173K
KPTIKaryopharm Therapeutics Inc.29,791$166K
SGMTSagimet Biosciences Inc.13,086$68K
EDITEditas Medicine, Inc.10,169$25K
GERNGERON CORP11,500$17K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Baird Financial Group, Inc. — Biotech 13F Holdings & Portfolio | BioSniper